1. Home
  2. KNSA vs QLYS Comparison

KNSA vs QLYS Comparison

Compare KNSA & QLYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kiniksa Pharmaceuticals Ltd.

KNSA

Kiniksa Pharmaceuticals Ltd.

HOLD

Current Price

$47.48

Market Cap

3.4B

Sector

Health Care

ML Signal

HOLD

Logo Qualys Inc.

QLYS

Qualys Inc.

HOLD

Current Price

$93.49

Market Cap

3.8B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
KNSA
QLYS
Founded
2015
1999
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
3.8B
IPO Year
2018
2012

Fundamental Metrics

Financial Performance
Metric
KNSA
QLYS
Price
$47.48
$93.49
Analyst Decision
Strong Buy
Hold
Analyst Count
7
15
Target Price
$53.71
$138.07
AVG Volume (30 Days)
445.1K
663.7K
Earning Date
04-03-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
15.38
EPS
0.57
3.97
Revenue
$423,239,000.00
$321,607,000.00
Revenue This Year
$62.99
$9.89
Revenue Next Year
$33.30
$6.96
P/E Ratio
$82.68
$25.98
Revenue Growth
56.60
15.32
52 Week Low
$18.26
$101.61
52 Week High
$47.51
$155.47

Technical Indicators

Market Signals
Indicator
KNSA
QLYS
Relative Strength Index (RSI) 67.87 26.33
Support Level $43.55 $101.61
Resistance Level $47.51 $114.34
Average True Range (ATR) 1.67 6.23
MACD 0.26 -1.39
Stochastic Oscillator 95.93 7.18

Price Performance

Historical Comparison
KNSA
QLYS

About KNSA Kiniksa Pharmaceuticals Ltd.

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.

About QLYS Qualys Inc.

Qualys is a cloud security and compliance solutions provider that helps businesses identify and manage their security risks and compliance requirements. The California-based company has more than 10,000 customers worldwide, the majority of which are small- and medium-size businesses. Qualys was founded in 1999 and went public in 2012.

Share on Social Networks: